- Home
- COCO vs DYN Comparison
COCO vs DYN Comparison
Compare COCO & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COCO
- DYN
- Stock Information
- Founded
- COCO 2004
- DYN 1984
- Country
- COCO United States
- DYN United States
- Employees
- COCO N/A
- DYN N/A
- Industry
- COCO Beverages (Production/Distribution)
- DYN Medicinal Chemicals and Botanical Products
- Sector
- COCO Consumer Staples
- DYN Health Care
- Exchange
- COCO Nasdaq
- DYN Nasdaq
- Market Cap
- COCO 2.2B
- DYN 1.9B
- IPO Year
- COCO 2021
- DYN 2020
- Fundamental
- Price
- COCO $39.57
- DYN $13.15
- Analyst Decision
- COCO Buy
- DYN Strong Buy
- Analyst Count
- COCO 8
- DYN 14
- Target Price
- COCO $38.00
- DYN $34.93
- AVG Volume (30 Days)
- COCO 823.0K
- DYN 2.3M
- Earning Date
- COCO 10-29-2025
- DYN 11-11-2025
- Dividend Yield
- COCO N/A
- DYN N/A
- EPS Growth
- COCO 14.02
- DYN N/A
- EPS
- COCO 1.07
- DYN N/A
- Revenue
- COCO $559,879,000.00
- DYN N/A
- Revenue This Year
- COCO $14.92
- DYN N/A
- Revenue Next Year
- COCO $11.92
- DYN N/A
- P/E Ratio
- COCO $37.10
- DYN N/A
- Revenue Growth
- COCO 11.97
- DYN N/A
- 52 Week Low
- COCO $25.79
- DYN $6.36
- 52 Week High
- COCO $40.41
- DYN $37.08
- Technical
- Relative Strength Index (RSI)
- COCO 69.74
- DYN 57.48
- Support Level
- COCO $37.92
- DYN $12.62
- Resistance Level
- COCO $39.39
- DYN $14.35
- Average True Range (ATR)
- COCO 1.30
- DYN 0.68
- MACD
- COCO 0.45
- DYN -0.13
- Stochastic Oscillator
- COCO 88.06
- DYN 30.72
About COCO The Vita Coco Company Inc.
The Vita Coco Co Inc is a plant-based functional hydration platform. Its products include Vita Coco Coconut Water, Private Label including coconut water and oil, and Other including Runa, Ever & Ever, and PWR LIFT product offerings, Vita Coco product extensions beyond coconut water, such as Vita Coco Sparkling, coconut milk products, and others. The company has two segments: The Americas segment which comprises of operations in the U.S. and Canada; and The International segment that comprises of operations in Europe, the Middle East, Africa and the Asia Pacific regions. The Americas segment derives maximum revenue. Geographical presence of the company is in United States, United Kingdom and All other countries.
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.